Perception of Saudi Population about COVID‑19: A Cross‑Sectional Study

Mohammad Eid M. Mahfouz, Bashaier G. AlQahtani

Abstract


Background: The evolving COVID‑19 outbreak requires a high level of population awareness and other measures to protect public health. Objectives: In this study, we aimed to identify knowledge, awareness, and fears of the Saudi population regarding COVID‑19 during this pandemic. Methods: A cross‑sectional survey study was conducted from April to May 2020 in different Saudi areas. Data were collected via online survey software (Google Forms), and the data collection tool was developed and validated by the study authors to fulfill the study objectives. Data were analyzed using SPSS version 21.0. Descriptive statistics and Chi‑square tests were used for comparison between groups. The statistical significance was considered when the P value ≤0.05. Results: Study participants included 2982 people with 66.8% females. The average percentage of the awareness levels of the current study population was 68%. The vast majority (95.1%) did not know how the virus spread while 94.7% of the participants know the distance that a person should maintain from another person. Significantly higher percentages (70%) knew about and were aware of the prevention methods, including social distancing and hand hygiene, and 73.5% knew that elderly people with chronic diseases are the highest risk group to become infected. The highest significant fear of COVID‑19 was from lack of treatment, which was reported by 77.5% of the participants with a P value of <0.05. Conclusions: Our study shows that the population has acceptable knowledge about COVID‑19. Education and work‑based awareness programs about COVID‑19 are needed, especially for prevention and treatment aspects.

Keywords


Awareness; COVID‑19; fears; knowledge; Saudi Arabia

Full Text:

PDF

References


Rothan HA, Byrareddy SN. The epidemeology and pathogensis

of coronavirus (Covid‑19) outbreak. J Autoimmun 2020;109:1‑4.

World Health Organization (WHO). Novel Coronavirus

(2019‑nCoV) Situation Report‑1 21 January 2020. WHO Bull

:1‑7.

Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al.

Current status of epidemiology, diagnosis, therapeutics, and

vaccines for novel coronavirus disease 2019 (COVID‑19).

J Microbiol Biotechnol 2020;30:313‑24.

Available from: https://www.cdc.gov/healthywater/hygiene/

etiquette/coughing_sneezing.html, Centers for Disease Control

and Prevention, May, 2020, Coughing and Sneezing.

Culp WC Jr. Coronavirus disease 2019: In‑home isolation room

construction. A A Pract 2020;14:e01218.

Remuzzi A, Remuzzi G. COVID‑19 and Italy: What next?

Lancet 2020;395:1225‑8.

Jit M, Jombart T, Nightingale ES, Endo A, Abbott S, Edmunds

WJ. Estimating number of cases and spread of coronavirus

disease 2019 (covid-19) in the United Kingdom using Critical

Care Admissions, February to March 2020. 2020:1-5.

Berry I, Soucy JPR, Tuite A, Fisman D. Open access

epidemiologic data and an interactive dashboard to monitor the

COVID‑19 outbreak in Canada. CMAJ 2020;192:E420.

Health Ministry of Coronavirus Disease 19 Guidelines.

;19(February).

Available from: https://www.worldometers.info/

coronavirus/?utm_campaign=homeAdvegas1%3F+, Worldometer,

, May, 2020, Coronavirus Cases.

Lu SH, Tian BC, Kang XP, Zhang W, Meng XP, Zhang JB, et al.

Public awareness of tuberculosis in China: A national survey of

253 subjects. Int J Tuberc Lung Dis 2009;13:1493‑9.

Ahmed EF, Shehata MAA, Elheeny AAH. COVID‑19

awareness among a group of Egyptians and their perception

toward the role of dentists in its prevention: A pilot

cross‑sectional survey. J Public Health (Berl) 2020. doi:

1007/s10389‑020‑01318‑8.

Al‑Hanawi MK, Angawi K, Alshareef N, Qattan AMN,

Helmy HZ, Abudawood Y, et al. Knowledge, attitude and practice

toward COVID‑19 among the public in the Kingdom of Saudi

Arabia: A cross‑sectional study. Front Public Health 2020;8:217.

Geldsetzer P. Knowledge and perceptions of COVID‑19

among the general public in the United States and the United

Kingdom: A cross‑sectional online survey. Ann Intern Med

;173:157‑60.

Olaimat AN, Aolymat I, Shahbaz HM, Holley RA. Knowledge and

information sources about COVID‑19 among university students

in Jordan: A cross‑sectional study. Front Public Health 2020;8:254.

Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R.

COVID‑19 infection: Origin, transmission, and characteristics of

human coronaviruses. J Adv Res 2020;24:91‑8.

Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT,

Le HQ, et al. Importation and human‑to‑human transmission of a

novel coronavirus in Vietnam. N Engl J Med 2020;382:872‑4.

Parry J. China coronavirus: Cases surge as official admits human

to human transmission. BMJ 2020;368:m236.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al.

Early transmission dynamics in Wuhan, China, of

novel coronavirus‑infected pneumonia. N Engl J Med

;382:1199‑207.

Zhong B‑L, Luo W, Li H‑M, Zhang Q‑Q, Liu X‑G, Li W‑T,

et al. Knowledge, attitudes, and practices towards COVID‑19

among Chinese residents during the rapid rise period of the

COVID‑19 outbreak: A quick online cross‑sectional survey. Int J

Biol Sci 2020;16:1745‑52.

Machida M, Nakamura I, Saito R, Nakaya T, Hanibuchi T,

Takamiya T, et al. Adoption of personal protective measures by

ordinary citizens during the COVID‑19 outbreak in Japan. Int J

Infect Dis 2020;94:139‑44.

Naser AY, Dahmash EZ, Alwafi H, Alsairafi ZK, Rajeh AMA,

Alhartani YJ, et al. Knowledge and practices towards COVID‑19

during its outbreak: A multinational cross‑sectional study.

medRxiv 2020. doi: 10.1101/2020.04.13.20063560.

Centers for Disease Control and Prevention. People who

are at higher risk for severe illness. Coronavirus Disease

(COVID‑19). 2020. Available from: https://www.

cdc.gov/coronavirus/2019‑ncov/need‑extraprecautions/

people‑at‑higher‑risk.html. [Last accessed on 2020 Apr 01].

Public Health England. Guidance on social distancing for

everyone in the UK. March 30, 2020. Available from:

https://www.gov.uk/government/publications/covid‑19guidance‑on‑social-distancing‑and‑forvulnerable‑people/guidanc

e‑on‑social‑distancing‑for‑everyone‑inthe‑uk‑and‑protecting‑old

er-people‑and‑vulnerable‑adults. [Last accessed on 2020 Apr 01].

WHO. COVID‑19 and NCDs. Information note on

COVID‑19 and noncommunicable diseases. March 23, 2020.

Available from: https://www.who.int/who‑documents‑detail/

covid‑19‑and‑ncds. [Last accessed on 2020 Jun 08].

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R.

Features, evaluation and treatment coronavirus (COVID‑19).

StatPearls, Treasure Island: StatPearls PublishingStatPearls

Publishing LLC.; 2020. [Links].

Peeri NC, Shrestha N, Rahman MH, Zaki R, Tan Z, Bibi S,

et al. The SARS, MERS and novel coronavirus (COVID‑19)

epidemics, the newest and biggest global health threats: What

lessons have we learned? Int J Epidemiol 2020;49:717‑26.

Malta M, Rimoin AW, Strathdee SA. The coronavirus

‑nCoV epidemic: Is hindsight 20/20? EClinicalMedicine

;20:100289.

Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M,

Benedek DM. Public responses to the novel 2019

coronavirus (2019 – nCoV) in Japan: Mental health consequences

and target populations. Psychiatry Clin Neurosci 2020;74:281‑2.